Uncategorized
Musk Vs. Trump ‘Soap Opera Must End’: Tesla Analyst Shares 3 Key Steps
Tesla analyst Dan Ives lays out 3 ways the company’s Board of Directors could oversee Musk’s political push and help protect shareholders. read more
Does Higher Dose Of Wegovy Result In More Weight Loss? Novo Nordisk Seeks European Approval
Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes. read more
Solar Stocks Get A Reprieve As Trump’s ‘Big Beautiful Bill’ Lands Softer Than Feared
Trump’s bill pressures renewable energy stocks but KeyBanc says upgrades for Sunrun and SolarEdge are ‘better than feared.’ Analyst sees stable near-term outlook for Sunrun and SolarEdge amid changes to tax credits. Latest Ratings for RUN Date Firm Action From To Feb 2022 Wolfe Research Maintains Outperform Jan 2022 Truist Securities Maintains Buy Dec 2021…